#Orakl Oncology

Coverage of Orakl Oncology focuses on the company’s progress at the intersection of oncology, venture capital, and AI-driven healthcare innovation. This archive brings together reporting on the startup’s development, funding context, and broader implications for data-driven cancer research and treatment.

Orakl Oncology raises $34M Series

The Paris-based cancer AI startup said the oversubscribed round was co-led by Norrsken VC

Nov 15, 2026 · 4 min